Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-15 Purchase | 2024-10-17 4:17 pm | Upstream Bio Inc. | UPB | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. Director 10% Owner | 825,000 | $17 | $14,025,000 | 4,554,873 (Indirect) | View |
| 2024-09-19 Sale | 2024-09-23 4:51 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 39,300 | $0.71 | $27,903 | 7,794,569 (Indirect) | View |
| 2024-09-16 Sale | 2024-09-18 6:38 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 200,131 | $0.73315 | $146,727 | 7,833,869 (Indirect) | View |
| 2024-09-16 Purchase | 2024-09-17 8:13 pm | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 750,000 | $16 | $12,000,000 | 653,787 (Indirect) | View |
| 2024-08-26 Sale | 2024-08-28 4:26 pm | ARS Pharmaceuticals Inc. | SPRY | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director | 83,695 | $13 | $1,088,035 | 8,288,510 (Indirect) | View |
| 2024-08-21 Sale | 2024-08-23 6:38 pm | ARS Pharmaceuticals Inc. | SPRY | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director | 868,682 | $13.24 | $11,497,963 | 8,372,205 (Indirect) | View |
| 2024-08-13 Sale | 2024-08-15 5:01 pm | Keros Therapeutics Inc. | KROS | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director | 250,000 | $44.01 | $11,002,500 | 119,522 (Indirect) | View |
| 2024-08-13 Purchase | 2024-08-15 4:51 pm | scPharmaceuticals Inc. | SCPH | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC 10% Owner | 500,000 | $4 | $2,000,000 | 252,858 (Indirect) | View |
| 2024-07-15 Sale | 2024-07-17 8:48 pm | Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd OrbiMed Genesis GP LLC Director 10% Owner | 56,164 | $10 | $561,640 | 755,635 (Indirect) | View |
| 2024-06-28 Sale | 2024-07-02 4:54 pm | TELA Bio Inc. | TELA | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner | 428,300 | $4.721 | $2,022,000 | 2,407,242 (Indirect) | View |
| 2024-06-17 Purchase | 2024-06-20 5:19 pm | Disc Medicine Inc. | IRON | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 83,334 | $36 | $3,000,024 | 235,391 (Indirect) | View |
| 2024-05-16 Sale | 2024-05-20 5:00 pm | Enliven Therapeutics Inc. | ELVN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 1,033,300 | $22.14 | $22,877,262 | 7,663,349 (Indirect) | View |
| 2024-05-01 Sale | 2024-05-03 5:16 pm | NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 29,206 | $14.02 | $409,426 | 3,406,335 (Indirect) | View |
| 2024-04-24 Sale | 2024-04-26 5:01 pm | NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 1,781 | $14.06 | $25,041 | 3,435,541 (Indirect) | View |
| 2024-04-19 Sale | 2024-04-23 6:38 pm | NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 64,653 | $14.12 | $913,057 | 3,437,322 (Indirect) | View |
| 2024-04-16 Sale | 2024-04-18 5:10 pm | NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 16,992 | $14.02 | $238,231 | 3,501,975 (Indirect) | View |
| 2024-04-11 Sale | 2024-04-15 5:25 pm | NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 485,000 | $14.49 | $7,026,033 | 3,518,967 (Indirect) | View |
| 2024-01-30 Purchase | 2024-01-31 4:12 pm | ArriVent Biopharma Inc. | AVBP | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors IV Ltd OrbiMed Asia GP IV L.P. Director 10% Owner | 444,444 | $18 | $7,999,992 | 1,513,664 (Indirect) | View |
| 2024-01-25 Purchase | 2024-01-26 7:14 pm | Adicet Bio Inc. | ACET | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. OrbiMed Israel GP Ltd. OrbiMed Israel BioFund GP Limited Partnership Director 10% Owner | 3,125,000 | $2.4 | $7,500,000 | 2,930,527 (Indirect) | View |
| 2024-01-23 Purchase | 2024-01-25 4:28 pm | Edgewise Therapeutics Inc. | EWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director 10% Owner | 454,545 | $11 | $4,999,995 | 14,756,096 (Indirect) | View |
| 2023-12-27 Sale | 2023-12-29 4:18 pm | ALPINE IMMUNE SCIENCES INC. | ALPN | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director | 1,546,347 | $18.54 | $28,671,734 | 264,315 (Indirect) | View |
| 2023-12-18 Sale | 2023-12-20 6:28 pm | Disc Medicine Inc. | IRON | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 1,724 | $59.24 | $102,130 | 1,702,237 (Indirect Direct) | View |
| 2023-12-14 Sale | 2023-12-15 6:04 pm | Disc Medicine Inc. | IRON | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 433,200 | $56.75 | $24,584,100 | 224,405 (Indirect) | View |
| 2023-12-12 Sale | 2023-12-14 5:44 pm | Disc Medicine Inc. | IRON | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 134,200 | $58.88 | $7,902,266 | 727,807 (Indirect) | View |
| 2023-11-22 Sale | 2023-11-24 4:38 pm | PMV Pharmaceuticals Inc. | PMVP | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC 10% Owner | 87,786 | $2.23 | $195,763 | 6,475,291 (Indirect) | View |
| 2023-10-02 Sale | 2023-10-04 5:36 pm | NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 8,314 | $9.0749 | $75,449 | 4,003,967 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-01 Conversion | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 539,062 | $3.2 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 1,233,506 | $0 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Option Award | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 1,443,750 | $4 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 694,444 | $3.6 | 2,677,256 (Indirect) | View | |
| 2024-10-15 Conversion | 2024-10-17 4:17 pm | N/A N/A | Upstream Bio Inc. | UPB | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. Director 10% Owner | 7,219,578 | $0 | 4,554,873 (Indirect) | View |
Ownership | 2024-10-10 8:09 pm | N/A N/A | Upstream Bio Inc. | UPB | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. Director 10% Owner | 0 | $0 | 4,868,589 (Indirect) | View |
Ownership | 2024-09-23 4:42 pm | N/A N/A | Traws Pharma Inc. | TRAW | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC 10% Owner | 0 | $0 | 1,278,469 (Indirect) | View |
| 2024-09-16 Conversion | 2024-09-17 8:13 pm | N/A N/A | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 39,876,501 | $0 | 653,787 (Indirect) | View |
Ownership | 2024-09-12 7:14 pm | N/A N/A | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 0 | $0 | 3,062,215 (Indirect) | View |
| 2024-05-18 Equity Swap | 2024-05-20 7:47 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director | 2,680,496 | $0 | 0 (Indirect) | View |
Ownership(A) | 2024-04-12 4:11 pm | N/A N/A | Traws Pharma Inc. | TRAW | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC See Remarks | 0 | $0 | 31,961,744 (Indirect) | View |
| 2024-04-03 Disposition | 2024-04-05 4:33 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 8,009,729 | $0 | 0 (Indirect) | View |
Ownership | 2024-04-03 7:56 pm | N/A N/A | Traws Pharma Inc. | TRAW | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC 10% Owner | 0 | $0 | 26,729,195 (Indirect) | View |
Ownership | 2024-03-27 5:17 pm | N/A N/A | Q32 Bio Inc. | QTTB | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC Director 10% Owner | 0 | $0 | 2,252,987 (Indirect) | View |
| 2024-02-14 Equity Swap | 2024-02-14 4:02 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 17,713,600 | $0 | 0 (Indirect) | View |
| 2024-01-30 Conversion | 2024-01-31 4:12 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors IV Ltd OrbiMed Asia GP IV L.P. Director 10% Owner | 2,582,884 | $0 | 1,513,664 (Indirect) | View |
Ownership | 2024-01-25 8:40 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors IV Ltd OrbiMed Asia GP IV L.P. Director 10% Owner | 0 | $0 | 2,582,884 (Indirect) | View |
| 2024-01-11 Exercise | 2024-01-16 4:39 pm | 2019-01-18 2024-01-18 | ALPINE IMMUNE SCIENCES INC. | ALPN | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director | 145,251 | $0 | 2,680,496 (Indirect) | View |
| 2024-01-11 Exercise | 2024-01-16 4:39 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director | 145,251 | $12.74 | 2,680,496 (Indirect) | View |
| 2023-12-18 Exercise | 2023-12-20 6:28 pm | N/A 2031-10-03 | Disc Medicine Inc. | IRON | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 1,724 | $0 | 1,702,237 (Direct) | View |
| 2023-12-18 Exercise | 2023-12-20 6:28 pm | N/A N/A | Disc Medicine Inc. | IRON | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 1,724 | $38 | 1,702,237 (Direct) | View |